KS

Kamna Sohgaura

Active Director Director DIN 10721367
DIN 10721367 First appointment Jul 2024 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2024
Shareholding value •••• Premium profile

About Kamna Sohgaura

Data last updated:

Kamna Sohgaura is a Director at Rosylyn Pharmaceuticals Private Limited (since 2024). The company operates in Pharma. Rosylyn Pharmaceuticals Private Limited reported revenue of ₹87 Lakh (FY 2024).

DIN 10721367
Primary Designation Director
Industry Pharma
First Appointment 27 Jul 2024
Oldest Company Age 7 yrs
Largest company Rosylyn Pharmaceuticals Private Limited · ₹87 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director27 Jul 20242019₹87 Lakh (FY 2024)Active

Directorship timeline

Open interactive timeline →
Rosylyn Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Kamna Sohgaura

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kamna Sohgaura

Kamna Sohgaura currently holds 1 directorship: Rosylyn Pharmaceuticals Private Limited (Director, since 27 Jul 2024, revenue ₹87 Lakh (FY 2024)).

Kamna Sohgaura was first appointed on 27 Jul 2024 as Director at Rosylyn Pharmaceuticals Private Limited.

The current boards of Kamna Sohgaura's companies include Kalpana Patel (Rosylyn Pharmaceuticals Private Limited), Pankaj Kumar Patel (Rosylyn Pharmaceuticals Private Limited), Vibhav Pandey (Rosylyn Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available